Stockreport

Raytheon Is One Of The Cheapest Defense Stocks - Cramer's Lightning Round (10/4/18) [Seeking Alpha]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Summary Nektar Therapeutics is a speculative buy. Buy Align Technology at $335-340 in stages. Constellation Brands is a better pick than Anheuser-Busch InBev. [Read more]